Lehrstuhl für Pharmazeutische Technologie und Biopharmazie
Lorenz Meinel has not added Biography.
If you are Lorenz Meinel and would like to personalize this page please email our Author Liaison for assistance.
Nanotransporters for drug delivery.
Current opinion in biotechnology 06, 2016 | Pubmed ID: 26773302
Quinolone Amides as Antitrypanosomal Lead Compounds with In Vivo Activity.
Antimicrobial agents and chemotherapy 08, 2016 | Pubmed ID: 27139467
Prevention of colitis by controlled oral drug delivery of carbon monoxide.
Journal of controlled release : official journal of the Controlled Release Society 10, 2016 | Pubmed ID: 27578097
Water-Soluble Triarylborane Chromophores for One- and Two-Photon Excited Fluorescence Imaging of Mitochondria in Cells.
Chemistry (Weinheim an der Bergstrasse, Germany) Oct, 2016 | Pubmed ID: 27627995
Matrix Metalloproteinase Responsive Delivery of Myostatin Inhibitors.
Pharmaceutical research Jan, 2017 | Pubmed ID: 27628627
Localized delivery of carbon monoxide.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V Sep, 2017 | Pubmed ID: 27836646
Site-Directed Immobilization of BMP-2: Two Approaches for the Production of Innovative Osteoinductive Scaffolds.
Biomacromolecules 03, 2017 | Pubmed ID: 28211679
Opening NADPH oxidase inhibitors for in vivo translation.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V Jun, 2017 | Pubmed ID: 28284727
Diagnosing peri-implant disease using the tongue as a 24/7 detector.
Nature communications 08, 2017 | Pubmed ID: 28811549
Mapping the pharmaceutical design space by amorphous ionic liquid strategies.
Journal of controlled release : official journal of the Controlled Release Society Dec, 2017 | Pubmed ID: 29097303
Bioorthogonal strategies for site-directed decoration of biomaterials with therapeutic proteins.
Journal of controlled release : official journal of the Controlled Release Society Mar, 2018 | Pubmed ID: 29360478
Claudia Siverino1,
Barbara Tabisz2,
Tessa Lühmann3,
Lorenz Meinel3,
Thomas Müller4,
Heike Walles1,2,
Joachim Nickel1,2
1Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik (IGB), Translationszentrum Würzburg 'Regenerative Therapien für Krebs- und Muskuloskelettale Erkrankung', Institutsteil Würzburg,
2Lehrstuhl für Tissue Engineering und Regenerative Medizin, Universitätsklinikum Würzburg,
3Lehrstuhl für Pharmazeutische Technologie und Biopharmazie, Universität Würzburg,
4Lehrstuhl für molekulare Pflanzenphysiologie und Biophysik, Julius-von-Sachs Institut für Biowissenschaften, Universität Würzburg
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved